MedTrace Logo

A Study to Assess Choroideremia (CHM) Health Outcomes

NCT04750785 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2021-10-14

No results posted yet for this study

Summary

The primary objectives of this study are to describe disease progression and severity by age in participants with CHM, to assess health-related quality-of-life, resource utilization and work productivity, and to assess quality-of-life, work productivity, and impact on daily activities in caregivers of participants with CHM at different stages of disease progression.

Conditions

  • Choroideremia

Interventions

OTHER

No Intervention

Administered as specified in the treatment arm.

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Biogen

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2021-09-27
Completion
2021-09-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04750785 on ClinicalTrials.gov